The IPO Buzz: Turnstone Biologics (TSBX Proposed) Launches $75 Million IPO
Cancer biotech Turnstone Biologics (TSBX proposed) set terms for its $75.4 million IPO and launched the deal early today (Monday, July 17, 2023) for pricing at the end of the week. Turnstone’s launch marks the fourth biotech IPO this month. The La Jolla, California-based biotech plans to offer 5.8 million shares at $12.00 to $14.00. […]
July 17, 2023 Read More